SMFL: Smart for Life, Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 0.41
Enterprise Value ($M) 13.31
Book Value ($M) 0.95
Book Value / Share 1.19
Price / Book 0.43
NCAV ($M) -22.04
NCAV / Share -27.66
Price / NCAV -0.02

Profitability (mra)
Return on Invested Capital (ROIC) -1.28
Return on Assets (ROA) -0.76
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.04
Current Ratio 0.18

Balance Sheet (mrq) ($M)
Current Assets 2.55
Assets 25.54
Liabilities 24.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Ionic Ventures, LLC 9.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 ☐ TRANSITION REP
2023-08-23 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 ☐ TRANSITION REPORT P
2023-05-22 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10−Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 ☐ TRANSITION REPORT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-12 131,582 587,447 22.40
2024-04-11 115,120 97,538 118.03
2024-04-10 413,214 1,907,664 21.66
2024-04-09 769,036 3,915,561 19.64
2024-04-08 13,760,275 47,970,275 28.69

(click for more detail)

Similar Companies
SHPH – Shuttle Pharmaceuticals Holdings, Inc. SLRX – Salarius Pharmaceuticals, Inc.
SLS – SELLAS Life Sciences Group, Inc. SNDL – SNDL Inc.
SNGX – Soligenix, Inc.


Financial data and stock pages provided by
Fintel.io